Packaged food intake by British children aged 0 to 6 years

E Foster1, J C Mathers, A J Adamson

  • 1Human Nutrition Research Centre, Medical School, William Leech Building, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. Emma.Foster@ncl.ac.uk

Insights

Children consume more food per body weight and have higher plastic packaging exposure than assumed by European Union safety models. This study highlights potential risks from chemical migration in children's food packaging.

Area of Science:

  • Food safety and toxicology
  • Consumer product safety
  • Pediatric exposure assessment

Background:

  • European Union (EU) safety assessments for chemical migrants from plastic food packaging use standardized exposure values (16.7 g/kg body weight/day).
  • Current EU models may underestimate children's exposure due to higher food intake per body weight and smaller food portion packaging.
  • Children may face increased risks from chemical migration due to these factors.

Purpose of the Study:

  • To evaluate the European Union's chemical migration exposure model for children's food.
  • To determine if modifications are needed to ensure specific protection for children.
  • To assess actual food intake and packaging contact area per body weight in young children.

Main Methods:

  • Collected 4-day food intake data from 297 children aged 0-6 years.
  • Recorded food types, pack sizes, and food-contact material area-to-food mass ratios.
  • Calculated mean food intake and packaging contact area per kilogram of body weight.

Main Results:

  • Children's mean food intake from plastic packaging ranged from 27 to 51 g/kg body weight, exceeding the EU's 16.7 g/kg assumption.
  • Mean packaging contact area per body weight ranged from 0.65 to 0.81 dm²/kg.
  • All children studied exceeded the EU's assumed packaging contact area of 0.1 dm²/kg body weight.

Conclusions:

  • The European Union's current exposure model for chemical migrants from plastic food packaging is inadequate for children.
  • Children exhibit significantly higher food intake and packaging contact per body weight than assumed.
  • The study supports the need for revised EU models to ensure adequate protection against chemical migration for pediatric populations.

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Sources of Food Contamination01:29

Sources of Food Contamination

Contamination of food by microbial agents and natural toxins poses significant risks to public health. These hazards can be introduced at various points across the food supply chain, ranging from environmental sources to processing and storage stages. Understanding these contamination pathways is critical for developing strategies to ensure food safety.Seafood is particularly vulnerable to contamination through both environmental exposure and microbial colonization. Toxins from harmful algal...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...